Paratek Pharmaceuticals Promotes Evan Loh, M.D. to Chief Executive Officer; Michael Bigham to Assume Role of Executive Chairman

NEXT STORY
AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results
PREV STORY
Predictive Genetic Testing and Consumer Wellness Genomics Market Size Worth Around US$ 9 Billion by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Provectus Biopharmaceuticals Receives Notice of Allowance for Adult Solid Tumor Cancer Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Announces Interim Results Demonstrating Anti-Tumor Activity of CPI-444 in Renal and Lung Cancer Patients Resistant or Refractory to Prior PD-(L)1 Treatment

-- Clinical Data from Company’s Ongoing Phase 1/1b Study in Expansion Cohorts Presented in ...

author_avatar
NASDAQ Market News

BioXcel Therapeutics Launches “Boiling Point” Educational Campaign to Shed Light on the Importance of Prompt and Cooperative De-escalation in the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders

author_avatar
NASDAQ Market News